Dr. Kathy High discusses the company history, unique workforce and the future of the gene therapy industry.
Our region is a hotbed for gene and cell therapy innovation. How do we maximize this moment?
Dr. Kathy High and Jean Bennett reflect on bringing patients and their families the first and only gene therapy approved by both U.S. and EU regulators for an inherited disease.
I’m optimistic about the future of Pompe disease, or better yet, a future without the devastating symptoms of Pompe disease.
For many of us, the term “modern medicine” is synonymous with breakthrough treatments for cancer, HIV/AIDS and other chronic diseases.